Source link : https://www.newshealth.biz/health-news/newer-diabetes-drugs-still-under-prescribed-in-high-risk-patients/
NEW ORLEANS — Patients at a community health center who had type 2 diabetes and a high risk of atherosclerotic cardiovascular disease (ASCVD) were under-prescribed guideline-recommended treatment with sodium-glucose cotransporter-2 (SGLT-2) inhibitors or glucagon-like peptide-1 (GLP-1) receptor agonists, a single-center study found. Of patients who met the high-risk criteria, 55% were not on American Diabetes […]
Author : News Health
Publish date : 2024-12-16 16:46:23
Copyright for syndicated content belongs to the linked Source.